The combination of TPA and CA-125 therefore showed a good diagnostic ability in the detection of malignant tumors not only concerning ovarian cancer but also in the whole study cohort consisting of healthy women, as well as ovarian and uterine benign and malignant cases. This evidence concerns the gene MUC16 and ovarian carcinoma.